Ongoing nausea and headache
Pro Research Analysisby 
Searched over 200M research papers
Ongoing Nausea and Headache: Insights from Recent Research
Persistent Nausea and Chronic Migraine
Persistent Frequent Nausea (PFN) and Migraine Progression
Persistent frequent nausea (PFN) is a significant predictor of the progression from episodic migraine (EM) to chronic migraine (CM). Research from the American Migraine Prevalence and Prevention (AMPP) study indicates that individuals with EM who experience PFN are at a higher risk of developing CM . This highlights the importance of addressing nausea in migraine management to potentially prevent the worsening of the condition.
Impact of Nausea on Migraine Sufferers
Nausea is a common and debilitating symptom for many migraine sufferers. Studies show that persistent nausea is associated with greater pain severity, reduced quality of life, and impaired functional ability Lipton2012Lipton2013. This symptom affects a significant portion of migraineurs, with 45.2% reporting frequent nausea, which is more prevalent among females and those with higher levels of depression and headache impact .
New Daily Persistent Headache (NDPH) and Nausea
NDPH and Treatment Challenges
New daily persistent headache (NDPH) is a primary headache disorder that often presents with persistent nausea and is resistant to standard headache treatments. A case study reported the successful use of mirtazapine in alleviating nausea in a patient with medication-refractory NDPH, suggesting potential benefits of this treatment for similar cases . This highlights the need for innovative treatment approaches for NDPH-associated nausea.
Clinical Characteristics of NDPH
Patients with NDPH often experience severe, unremitting headaches accompanied by nausea, light and noise sensitivity, and other migrainous features. These symptoms can be as distressing as the headache itself, necessitating comprehensive management strategies .
Medication-Induced Nausea
CGRP Inhibitors and Gastrointestinal Side Effects
Calcitonin gene-related peptide (CGRP) inhibitors, used for preventing cluster headaches and migraines, have been associated with gastrointestinal side effects, including nausea. A systematic review and meta-analysis found that CGRP receptor antagonists are linked to higher rates of nausea compared to placebo, emphasizing the need for monitoring and managing these side effects in patients undergoing CGRP inhibitor therapy .
Unique Cases and Considerations
Gastrointestinal Symptoms in Migraineurs
Some migraine patients present with prominent gastrointestinal symptoms, such as nausea and vomiting, which can sometimes overshadow the headache itself. These patients may initially seek treatment from gastroenterologists rather than headache specialists, indicating the need for awareness and interdisciplinary collaboration in managing such cases .
Nausea and Vomiting in Pregnancy and Migraine
There is a notable overlap between hyperemesis gravidarum (severe nausea and vomiting during pregnancy) and migraine headaches. This suggests a potential common mechanism, possibly involving genetic factors related to olfaction and dopaminergic receptors, which warrants further investigation .
Conclusion
Ongoing nausea and headache are interlinked symptoms that significantly impact the lives of those affected. Persistent nausea is a critical factor in the progression and severity of migraines and NDPH, and innovative treatments like mirtazapine show promise in managing these symptoms. Additionally, medication-induced nausea, particularly from CGRP inhibitors, requires careful management. Understanding the complex relationship between gastrointestinal symptoms and headaches can lead to better, more comprehensive care for patients.
Sources and full results
Most relevant research papers on this topic